spacer
home > ebr > Autumn 2004
PUBLICATIONS

European Biopharmaceutical Review

ebr
Autumn 2004
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EBR provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of of biopharmaceuticals, take a look below at the range of articles featured in this issue of EBR.
   
Text
PDF
In her Editor's Letter, Dr Helen Tayton-Martin takes a look at the topics in this issue  
download pdf
Science and Innovation
Dr Majid Mehtali, Vice President of Research & Development at Vivalis SA, underlines the potential of Embryonic Stem Cells: Current and Future Industrial Applications  
download pdf
Unravelling the Mysteries of Alzheimer's - the search for a cure continues, by G Steven Burrill, CEO of Burrill & Company  
download pdf
Sunil Saini, Director of Biomaterials at Therics, maps the development of a new domain in A Perspective in Orthopaedic Tissue Engineering  
download pdf
Hans Herklots, Media and Investor Relations Director at IsoTis OrthoBiologics, looks at the potential transformation of orthopaedics, in Biologics are Entering the Orthopaedic Arena  
download pdf
bullet
Business Development and Financing
How are ideas transformed into a thriving business? Nigel Wild, Managing Director of Oxfordshire BioTechNet Ltd, discusses the options in Funding and Mentoring - The Keys to the Biotech Kingdom  
download pdf
In Technology Transfer from Universities, Tom Hockaday, Executive Director of Isis Innovations Ltd, welcomes the continuing interest in collaboration between academia and the business community  
download pdf
Incubators must form an integral part of our infrastructure for supporting young companies, asserts Toni Wanklin, Development Manager at UK Business Incubation, in Breaking Through The Barrier: How Bio-Incubators Support Tomorrow's World-Class Entrepreneurs  
download pdf
Fiona Brown, Public Relations Consultant, considers today's funding environment and the particular hurdles inherent in biotechnology in Uniting Science and Business: The Challenges for Biotech Start-ups  
download pdf
Science, finance and IPR: conditions for Finnish entrepreneurs uncovered in Challenges for Biotech Start-Ups: A Nordic Perspective, by Professor Kalevi Kairemo, Medical Director and Dr Oula Pe-ate Medina, CEO of CTT Cancer Targeting Technologies  
download pdf
Continuing from Part 1 in our summer issue, Beyond Financial Analysis - Scientific Due Diligence in Pharma and Biotech: Part 2 focuseson clinical trials. By Dr Konrad Burk, Founder of ClinDescience GmbH, William McCulloch, CMO of Gloucester Pharmaceuticals, Dr Alexander von Nieciecki, CEO of BioProof, and Dr Wolfgang Meyer, Senior Director of European Drug Regulatory Affairs and Dr Benno Rattel, Senior Director of Drug Development at GPC Biotech AG  
download pdf
bullet
Legal, Ethical and Regulatory
Valuing Innovation: Patient Access to Novel Therapies, by Alastair Kent, Director of the Genetic Interest Group, explores the disjunction between scientific advances and practical resources  
download pdf
Dr Sarah Rawlings, Policy and Information Officer at Breakthrough Breast Cancer, examines the 'postcode lottery' of UK health care in NICE Implementation - The Patient Perspective  
download pdf
bullet
Biodevelopment and Manufacturing
Dr Stephen Hammond, CEO of Scottish Biomedical, investigates the factors to be weighed in the Successful Outsourcing of Preclinical Drug Discovery  
download pdf
In Electronic Diary Solutions: Enhanced Collection of Patient Reported Outcomes Data, Dr Bill Byrom, Product Development Director at ClinPhone Group Ltd, details alternatives to the traditional paper-based diary that can reduce the likelihood of distorted results  
download pdf
Ivan N Rich, Founder, Chairman and CEO of HemoGenix, Inc, discusses Stem Cell Haemotoxicity Testing to Predict Toxic Side-Effects and as a Tool for Safety Monitoring during Drug Development  
download pdf
Dr Wendy M Shaw, Associate Director (Europe) of the Late Phase Group at Kendle International Inc, explains the function of post-marketing surveillance in recording and studying new adverse drug reactions in Opportunities and Challenges of Pan European Post-Marketing Surveillance Programmes  
download pdf
bullet
Drug Discovery
Identifying Appropriate RNA Interference Drug Candidates opens the door to a whole new class of treatments - by Dr David A Bumcrot, Director, Preclinical at Alnylam Pharmaceuticals, Inc  
download pdf
Angelika Bonin-Debs, Director of Business Development and Strategic Alliances at Xantos Bioscience, charts the advent of RNAi and its role in Loss-of-Function and Gain-of-Function - Two Complementing Genome-Wide Technologies For Drug Discovery and Target Validation  
download pdf
Automation and Robotics in High Throughput Protein Crystallography explained by Bernhard Rupp, Macromolecular Crystallography and Structural Genomics Group of the Lawrence Livermore National Laboratory, University of California  
download pdf
Methods of column protection are presented in Syringe Filter Efficiency and the Effect of Filtration on HPLC Column Life, by Dr Weibing Ding, Senior Staff Scientist and Larry Scheer, Business Development Manager at Pall Corporation  
download pdf
bullet
Regional Focus: Malaysia
Regu Chandar Gnanapragasam, Assistant Manager of the Industrial & Trade Division of the Penang Development Corporation, Simon Saxby, Chief Executive Officer at Alpha Biologics Sdn Bhd and Dr Malcolm Blackwell, Chief Executive Officer at Progenix Research Sdn Bhd, unveil a new development zone for biotech in Malaysian Biotechnology Initiative for the State of Penang  
download pdf
bullet
Regional Focus: Australia
Innovation, investment and government support - Nicola Watkinson, Senior Investment Commissioner, Europe, at Invest Australia, sets the scene in Australian Biotechnology - An Untapped Opportunity  
download pdf
bullet
Preview
CMP Information anticipate this year's BioTech Hot Spot, a unique networking facility at CPhI Worldwide/ICSE  
download pdf
Answering the growing need for partnership opportunities, BIO-Europe 2004: Europe's Largest Partnering Conference, Provides a Platform for Deal-Making and Investors  
download pdf
Tracing global industry trends in Resurgent, Refocused and On the Threshold - Insights from Ernst & Young's 11th Annual Global Biotechnology Report, by EBR Editor Helen Tayton-Martin  
download pdf
Advokat Lars Rambe, Head of Life Science at Adokatfirman Delphi & Co, compares IP systems in the EU and US in Commercialisation of Inventions from Scandinavian Universities - A Challenge and an Opportunity  
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July and October

News and Press Releases

Synpromics announces a research collaboration with GE Healthcare to extend the toolbox for production of biologics

Edinburgh, UK, 4th January 2017 – Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform.
More info >>

White Papers

SuperCapSyringe®

Weibel CDS AG

Safer, easier and faster drug delivery – Weibel CDS AG, Switzerland develops and produces innovative, user friendly, application oriented injections systems and devices. The SuperCapSyringe® product family upgrades your vial practically to a prefilled syringe. Based on a modular design, the syringe is fully adaptable to your application needs. It is supplied in different sizes and, as a novelty, with staked needles including a passive safety device.
More info >>

Industry Events

Partnerships in Clinical Trials Europe 2017

28-29 November 2017, RAI, Amsterdam

PCT Europe is back, bringing you the latest information from across the clinical trials spectrum and providing you with direct access to the industry's leading innovators. And this year, we're in Amsterdam!
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement